Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking

Alzheimer's and Dementia

Volumn 8, Issue 6, 2012, Pages 513-519

  Durazzo, Timothy C ^a,b   Insel, Philip S ^a   Weiner, Michael W ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Brain atrophy; Brain reward system; Brain volumes; Cigarette smoking; MRI

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR; BRAIN ATROPHY; BRAIN REGION; BRAIN REWARD EXECUTIVE OVERSIGHT SYSTEM; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ENTORHINAL CORTEX; FEMALE; FUSIFORM GYRUS; GERIATRIC PATIENT; HIPPOCAMPUS; HUMAN; INFERIOR FRONTAL GYRUS; INSULA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE FRONTAL GYRUS; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PARAHIPPOCAMPAL GYRUS; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; PSYCHIATRY; RHOMBENCEPHALIC ISTHMUS; SMOKING; SUBSTANCE ABUSE; SUPERIOR FRONTAL GYRUS; VOLUMETRY;

AGED; ATROPHY; BRAIN; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; SMOKING;

EID: 84867881424     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.10.006     Document Type: Article

References (46)

1. T.C. Durazzo, and D.J. Meyerhoff Neurobiological and neurocognitive effects of chronic cigarette smoking and alcoholism Front Biosci 12 2007 4079 4100
2. T.C. Durazzo, D.J. Meyerhoff, and S.J. Nixon Chronic cigarette smoking: implications for neurocognition and brain neurobiology Int J Environ Res Public Health 7 2010 3760 3791
3. H. Akiyama, J.S. Meyer, K.F. Mortel, Y. Terayama, J. Thornby, and S. Konno Normal human aging: factors contributing to cerebral atrophy J Neurol Sci 152 1997 39 49
4. A. Hayee, A. Haque, A. Anwarullah, and M. Rabbani Smoking enhances age related brain atrophy-a quantitative study with computed tomography Bangladesh Med Res Counc Bull 29 2003 118 124
5. K. Kubota, T. Matsuzawa, T. Fujiwara, T. Yamaguchi, K. Ito, H. Watanabe, and S. Ono Age-related brain atrophy enhanced by smoking: a quantitative study with computed tomography J Exp Med 153 1987 303 311
6. W.T. Longstreth Jr., A.M. Arnold, T.A. Manolio, G.L. Burke, N. Bryan, C.A. Jungreis, D. O'Leary, P.L. Enright, and L. Fried Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group Neuroepidemiology 19 2000 30 42
7. A.L. Brody, M.A. Mandelkern, M.E. Jarvik, G.S. Lee, E.C. Smith, J.C. Huang, R.G. Bota, G. Bartzokis, and E.D. London Differences between smokers and nonsmokers in regional gray matter volumes and densities Biol Psychiatry 55 2004 77 84
8. J. Gallinat, E. Meisenzahl, L.K. Jacobsen, P. Kalus, J. Bierbrauer, and T. Kienast Smoking and structural brain deficits: a volumetric MR investigation Eur J Neurosci 24 2006 1744 1750
9. X. Zhang, B.J. Salmeron, T.J. Ross, X. Geng, Y. Yang, and E.A. Stein Factors underlying prefrontal and insula structural alterations in smokers Neuroimage 54 2011 42 48
10. O.P. Almeida, G.J. Garrido, N.T. Lautenschlager, G.K. Hulse, K. Jamrozik, and L. Flicker Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease Am J Geriatr Psychiatry 16 2008 92 98
11. C. Bolego, A. Poli, and R. Paoletti Smoking and gender Cardiovasc Res 53 2002 568 576
12. B. Ross, and S. Bluml Magnetic resonance spectroscopy of the human brain Anat Rec 265 2001 54 84
13. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, and A.M. Namboodiri N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology Prog Neurobiol 81 2007 89 131
14. J. Gallinat, U.E. Lang, L.K. Jacobsen, M. Bajbouj, P. Kalus, D. von Haebler, F. Seifert, and F. Schubert Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3 T J Clin Psychopharmacol 27 2007 80 84
15. C.E. Krueger, D.L. Dean, H.J. Rosen, C. Halabi, M. Weiner, B.L. Miller, and J.H. Kramer Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease Alzheimer Dis Assoc Disord 24 2010 43 48
16. J.S. Fowler, N.D. Volkow, C.A. Kassed, and L. Chang Imaging the addicted human brain Sci Pract Perspect 3 2007 4 16
17. R.D. Baler, and N.D. Volkow Drug addiction: the neurobiology of disrupted self-control Trends Mol Med 12 2006 559 566
18. P.W. Kalivas, and N.D. Volkow The neural basis of addiction: a pathology of motivation and choice Am J Psychiatry 162 2005 1403 1413
19. N. Makris, M. Oscar-Berman, S.K. Jaffin, S.M. Hodge, D.N. Kennedy, and V.S. Caviness Decreased volume of the brain reward system in alcoholism Biol Psychiatry 64 2008 192 202
20. N.D. Volkow, G.J. Wang, J.S. Fowler, and F. Telang Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology Philos Trans R Soc Lond B Biol Sci 363 2008 3191 3200
21. S.G. Mueller, M.W. Weiner, L.J. Thal, R.C. Petersen, C. Jack, W. Jagust, J.Q. Trojanowski, A.W. Toga, and L. Beckett The Alzheimer's disease neuroimaging initiative Neuroimaging Clin N Am 15 2005 869 877 xi-xii
22. S.G. Mueller, M.W. Weiner, L.J. Thal, R.C. Petersen, C.R. Jack, W. Jagust, J.Q. Trojanowski, A.W. Toga, and L. Beckett Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers Dement 1 2005 55 66
23. M.D.E. Goodyear, K. Krleza-Jeric, and T. Lemmens The Declaration of Helsinki BMJ 335 2007 624 625
24. U.S. Food and Drug Administration. Code of Federal Regulations, Title 21, Volume 1, (Revised as of April 1, 2011) CITE: 21CFR50. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart= 50&showfr=1.
25. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, and D. Harvey The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J Magn Reson Imaging 27 2008 685 691
26. Gunter JL, Bernstein MA, Borowski B, Felmlee JP, Blezek D, Mallozzi R. Validation testing of the MRI calibration phantom for the Alzheimer's disease neuroimaging initiative study. ISMRM 14th Scientific Meeting and Exhibition, Seattle, WA; 2006.
27. A.M. Dale, B. Fischl, and M.I. Sereno Cortical surface-based analysis. I. Segmentation and surface reconstruction Neuroimage 9 1999 179 194
28. B. Fischl, M.I. Sereno, and A.M. Dale Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system Neuroimage 9 1999 195 207
29. B. Fischl, and A.M. Dale Measuring the thickness of the human cerebral cortex from magnetic resonance images Proc Natl Acad Sci U S A 97 2000 11050 11055
30. B. Fischl, A. van der Kouwe, C. Destrieux, E. Halgren, F. Ségonne, and D.H. Salat Automatically parcellating the human cerebral cortex Cereb Cortex 14 2004 11 22
31. C.M. Judd, and G.H. McClelland Data Analysis: A Model-Comparison Approach 1989 Harcourt Brace Jovanovich San Diego, CA
32. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J Roy Stat Soc 57 Series B 1995 289 300
33. J. Pinheiro, and D. Bates Mixed-Effects Models in S and S-PLUS 2000 Springer-Verlag New York, NY
34. N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L.M. Shaw, and J.Q. Trojanowski MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers Brain 132 Pt. 4 2009 1067 1077
35. R.L. Buckner Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate Neuron 44 2004 195 208
36. M.S. Mega, and J.L. Cummings Frontal-subcortical circuits and neuropsychiatric disorders J Neuropsychiatry Clin Neurosci 6 1994 358 370
37. E.T. Rolls, and F. Grabenhorst The orbitofrontal cortex and beyond: from affect to decision-making Prog Neurobiol 86 2008 216 244
38. V.A. Cardenas, L.L. Chao, C. Studholme, K. Yaffe, B.L. Miller, and C. Madison Brain atrophy associated with baseline and longitudinal measures of cognition Neurobiol Aging 32 2011 572 580
39. K.J. Anstey, C. von Sanden, A. Salim, and R. O'Kearney Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies Am J Epidemiol 166 2007 367 378
40. J.K. Cataldo, and S.A. Glantz Smoking cessation and Alzheimer's disease: facts, fallacies and promise Expert Rev Neurother 10 2010 629 631
41. M. Rusanen, M. Kivipelto, C.P. Quesenberry Jr., J. Zhou, and R.A. Whitmer Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia Arch Intern Med 171 2011 333 339
42. K.W. Garey, M.M. Neuhauser, R.A. Robbins, L.H. Danziger, and I. Rubinstein Markers of inflammation in exhaled breath condensate of young healthy smokers Chest 125 2004 22 26
43. B.T. Hawkins, R.C. Brown, and T.P. Davis Smoking and ischemic stroke: a role for nicotine Trends Pharmacol Sci 23 2002 78 82
44. Y. Tsushima, Y. Tanizaki, J. Aoki, and K. Endo MR detection of microhemorrhages in neurologically healthy adults Neuroradiology 44 2002 31 36
45. C. Bates, M. Jarvis, and G. Connolly Tobacco Additives: Cigarette Engineering and Nicotine Addiction 1999 Tobacco Control Program Boston, MA
46. J. Fowles, M. Bates, and D. Noiton The Chemical Constituents in Cigarettes and Cigarette Smoke: Priorities for Harm Reduction 2000 Epidemiology and Toxicology Group New Zealand Available at: http://www.moh.govt.nz/moh.nsf/ pagescm/1003/$File/chemicalconstituentscigarettespriorities.pdf